Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Matt Bryson from Wedbush issued a price target of $28.00 for AXTI on 2026-02-20 13:22:33.The adjusted price target was set to $28.00.At the time of the announcement, AXTI...
February 20, 2026 AXTI 23.48%
from Barrington issued a price target of $8.00 for TZOO on 2026-02-20 12:35:06.The adjusted price target was set to $8.00.At the time of the announcement, TZOO was...
February 20, 2026 TZOO 7.03%
from Deutsche Bank issued a price target of $412.00 for PRAX on 2026-02-20 12:25:09.The adjusted price target was set to $412.00.At the time of the announcement, PRAX...
February 20, 2026 PRAX 1.02%
from Robert W. Baird issued a price target of $433.00 for PRAX on 2026-02-20 12:02:14.The adjusted price target was set to $433.00.At the time of the announcement,
February 20, 2026 PRAX 1.02%
from Cantor Fitzgerald issued a price target of $7.00 for SATL on 2026-02-20 11:32:45.The adjusted price target was set to $7.00.At the time of the announcement, SATL...
February 20, 2026 SATL 9.82%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| DAVEW Dave Inc. Warrants | 0.50
28.15% | ||||||||||||||||||
| AXTI AXT, Inc. | 29.40
23.48% | ||||||||||||||||||
| TROO TROOPS, Inc. | 3.95
23.44% | ||||||||||||||||||
| RBOT Vicarious Surgical Inc. | 2.25
22.28% | ||||||||||||||||||
| RMNI Rimini Street, Inc. | 3.56
19.87% | ||||||||||||||||||
| PRLD Prelude Therapeutics Inco | 2.72
19.82% | ||||||||||||||||||
| NVNO enVVeno Medical Corporati | 11.86
18.72% | ||||||||||||||||||
| TLSI TriSalus Life Sciences, I | 5.45
18.22% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 2.50%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -6.11%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 0.44%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -0.46%